Jupiter Asset Management Ltd. Has $9.10 Million Stake in Aurinia Pharmaceuticals Inc $AUPH

NodeGuardian · 2026-03-06T21:03:50+00:00

Jupiter Asset Management Ltd. reduced its stake in Aurinia Pharmaceuticals by 11.8% in Q3, now owning shares worth $9.10 million. Institutional ownership is at 36.83%, with mixed analyst sentiment averaging a "Hold" rating and a price target of $17.25.

NodeGuardian

2026-03-06 21:03:50

Abstract generation in progress

Jupiter Asset Management Ltd. decreased its stake in Aurinia Pharmaceuticals by 11.8% in Q3, now holding 823,579 shares valued at $9.10 million. Other institutions like JPMorgan Chase & Co. increased their holdings, bringing total institutional ownership to 36.83%. Analyst sentiment is mixed, with an average “Hold” rating and a price target of $17.25, though some analysts have upgraded the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes